Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM/DSS mouse model
Abstract
The azoxymethane (AOM)/dextran sulfate sodium (DSS) murine model is commonly used to study
colitis-associated cancer. The human commensal bacterium, enterotoxigenic Bacteroides fragilis (ETBF)
secretes the Bacteroides fragilis toxin (BFT) which is necessary and sufficient to cause colitis. We report
that BALB/c mice infected with WT-ETBF and administered three cycles of AOM/DSS developed
numerous, large-sized polyps predominantly in the colorectal region. In addition, AOM/DSS-treated
BALB/c mice orally inoculated with wild-type nontoxigenic Bacteroides fragilis (WT-NTBF)
overexpressing bft (rETBF) developed numerous polyps whereas mice infected with WT-NTBF
overexpressing a biologically inactive bft (rNTBF) did not promote polyp formation. Unexpectedly, the
combination of AOM+ETBF did not induce polyp formation whereas ETBF+DSS did induce polyp
development in a subset of BALB/c mice. In conclusion, WT-ETBF promoted polyp development in
AOM/DSS murine model with increased colitis in BALB/c mice. The model described herein provides an
experimental platform for understanding ETBF-induced colonic tumorigenesis and studying colorectal
cancer in wild-type mice.